Abbott Declares 366th Consecutive Quarterly Dividend

ABBOTT PARK, Ill., June 12, 2015 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 24 cents per share.

This marks the 366th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Aug. 15, 2015, to shareholders of record at the close of business on July 15, 2015.

Abbott has increased its dividend payout for 43 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for 25 consecutive years.

About Abbott:
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 73,000 people.

Visit Abbott at www.abbott.com and connect with us on Twitter at @AbbottNews.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/abbott-declares-366th-consecutive-quarterly-dividend-300098418.html

SOURCE Abbott

Suggested Articles

A third spinal muscular atrophy treatment option is set to debut with the FDA’s approval for Roche’s Evrysdi, formerly known as risdiplam.

Already developing coronavirus treatments, Takeda struck a licensing deal to manufacture and market Novavax's vaccine candidate in Japan

Pfizer struck a deal to produce Gilead Sciences' remdesivir, which has been running short at some hard-hit U.S. hospitals.